FDA Guidance for Industry: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion.

Titel:
FDA Guidance for Industry: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion.
Herkunft/Verlag:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM320641.pdf

Dokumentenart:
Guidance for Industry
Inhalt:
Empfehlunge bezüglich der Reduktion von Leukozyten vor der Lagerung von Blut und Blutkomponeneten

Zurück

GMP Seminare nach Thema